LRPAP1
Basic information
Region (hg38): 4:3503612-3532446
Previous symbols: [ "A2MRAP", "RAP" ]
Links
Phenotypes
GenCC
Source:
- myopia 23, autosomal recessive (Limited), mode of inheritance: AR
- myopia 23, autosomal recessive (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myopia 23, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 23830514; 25525168 |
ClinVar
This is a list of variants' phenotypes submitted to
- Myopia 23, autosomal recessive (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LRPAP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 33 | 41 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 1 | 2 | 33 | 14 | 6 |
Variants in LRPAP1
This is a list of pathogenic ClinVar variants found in the LRPAP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-3512969-T-C | LRPAP1-related disorder | Likely benign (Aug 08, 2023) | ||
4-3512979-G-A | not specified | Uncertain significance (Nov 03, 2022) | ||
4-3512988-G-C | not specified | Uncertain significance (Apr 08, 2022) | ||
4-3512991-G-A | not specified | Uncertain significance (Jun 28, 2023) | ||
4-3514774-C-T | LRPAP1-related disorder | Likely benign (Dec 31, 2019) | ||
4-3514816-C-T | not specified | Likely benign (Jan 24, 2024) | ||
4-3514817-G-A | not specified | Uncertain significance (Mar 12, 2024) | ||
4-3514824-G-A | Benign (Jul 23, 2018) | |||
4-3514841-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
4-3514898-CGA-C | Myopia 23, autosomal recessive | Likely pathogenic (Mar 29, 2024) | ||
4-3516119-G-T | not specified | Likely benign (Sep 01, 2021) | ||
4-3516141-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
4-3516145-G-A | not specified | Likely benign (Sep 20, 2022) | ||
4-3516147-T-G | not specified | Uncertain significance (May 10, 2022) | ||
4-3516151-C-T | not specified | Uncertain significance (May 27, 2022) | ||
4-3516207-G-T | LRPAP1-related disorder | Likely benign (Jul 12, 2019) | ||
4-3518035-A-G | LRPAP1-related disorder | Benign (Apr 30, 2019) | ||
4-3518045-C-T | not specified | Uncertain significance (May 14, 2024) | ||
4-3518057-T-C | not specified | Uncertain significance (Oct 06, 2021) | ||
4-3518076-GGTCC-G | Myopia 23, autosomal recessive | Pathogenic (Mar 22, 2022) | ||
4-3518094-T-C | Uncertain significance (Sep 27, 2022) | |||
4-3518120-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
4-3518121-T-G | not specified | Uncertain significance (Dec 09, 2023) | ||
4-3518147-T-G | not specified | Uncertain significance (Dec 02, 2022) | ||
4-3518154-C-T | LRPAP1-related disorder | Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LRPAP1 | protein_coding | protein_coding | ENST00000500728 | 8 | 26184 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.50e-7 | 0.626 | 125718 | 0 | 30 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.03 | 272 | 228 | 1.19 | 0.0000147 | 2303 |
Missense in Polyphen | 85 | 79.651 | 1.0672 | 902 | ||
Synonymous | -1.07 | 122 | 108 | 1.13 | 0.00000798 | 681 |
Loss of Function | 1.05 | 12 | 16.6 | 0.721 | 7.08e-7 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000212 | 0.000212 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000133 | 0.000123 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000304 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Molecular chaperone for LDL receptor-related proteins that may regulate their ligand binding activity along the secretory pathway. {ECO:0000269|PubMed:7774585}.;
- Disease
- DISEASE: Myopia 23, autosomal recessive (MYP23) [MIM:615431]: A refractive error of the eye, in which parallel rays from a distant object come to focus in front of the retina, vision being better for near objects than for far. {ECO:0000269|PubMed:23830514}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cholesterol metabolism - Homo sapiens (human);integrin signaling pathway;Reelin signaling pathway;Lissencephaly gene (LIS1) in neuronal migration and development;Signaling events mediated by the Hedgehog family
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.551
- rvis_EVS
- 0.6
- rvis_percentile_EVS
- 82.83
Haploinsufficiency Scores
- pHI
- 0.128
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.802
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lrpap1
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype;
Gene ontology
- Biological process
- negative regulation of receptor internalization;negative regulation of very-low-density lipoprotein particle clearance;negative regulation of protein binding;transcytosis;regulation of receptor-mediated endocytosis;negative regulation of cell death;extracellular negative regulation of signal transduction;negative regulation of amyloid-beta clearance;positive regulation of amyloid-beta clearance
- Cellular component
- extracellular region;endosome;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment;Golgi apparatus;Golgi lumen;cis-Golgi network;plasma membrane;cell surface;endosome lumen;rough endoplasmic reticulum lumen
- Molecular function
- amyloid-beta binding;signaling receptor binding;protein binding;heparin binding;lipase binding;receptor antagonist activity;low-density lipoprotein particle receptor binding;very-low-density lipoprotein particle receptor binding